Copyright: ©Author(s) 2026.
World J Gastroenterol. May 28, 2026; 32(20): 114867
Published online May 28, 2026. doi: 10.3748/wjg.v32.i20.114867
Published online May 28, 2026. doi: 10.3748/wjg.v32.i20.114867
Table 1 General characteristics of the study population, n (%)
| Clinical value | n = 333 |
| Sex (female) | 190 (57.1) |
| Age at diagnosis, median (IQR) | 67 (58-75) |
| Total follow-up time, median (IQR) | 4 (2-6) |
| Initial diameter, cm, median (IQR) | 1.2 (0.8-1.9) |
| Final diameter, cm, median (IQR) | 1.4 (0.9-2.2) |
| IPMN size | |
| ≤ 1 cm | 146 (43.8) |
| > 1 cm, ≤ 2 cm | 121 (36.3) |
| > 2 cm, ≤ 3 cm | 40 (12.0) |
| > 3 cm | 26 (7.9) |
| IPMN location | |
| Body | 119 (35.7) |
| Head | 173 (52.0) |
| Tail | 41 (12.3) |
| ACCI | |
| 0-3, mild | 160 (48.0) |
| 4-10, moderate-severe | 173 (52.0) |
| Congestive heart failure | 19 (5.7) |
| Connective tissue disease | 2 (0.6) |
| COPD | 21 (6.3) |
| Dementia | 2 (0.6) |
| Diabetes | 56 (16.8) |
| Leukemia | 2 (0.6) |
| Liver disease | 84 (25.2) |
| Lymphoma | 7 (2.1) |
| Myocardial infarction history | 13 (3.9) |
| Severe chronic kidney disease | 12 (3.6) |
| Solid tumor history | 64 (19.2) |
| Stroke history | 9 (2.7) |
- Citation: Kayali S, Dibitetto S, Busatto A, Gaiani F, Pasta A, Calabrese F, Fantasia S, Caprioli S, Luzzi AP, De Angelis CG, Savarino EV, Laghi L, Giannini EG, Marabotto E. Optimizing branch-duct intraductal papillary mucinous neoplasms surveillance: Data-driven dimensional grouping for risk stratification and cost-effectiveness. World J Gastroenterol 2026; 32(20): 114867
- URL: https://www.wjgnet.com/1007-9327/full/v32/i20/114867.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i20.114867